Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · CareTrust REIT (CTRE)

CareTrust REIT Q4 net income nearly doubles to $52.1 million; 2025 guidance issued

Positive Impact 4 of 5 earnings Written later

CareTrust REIT reported fourth-quarter 2024 net income of $52.1 million, or $0.29 per diluted share, up from $26.3 million, or $0.22, a year earlier, and full-year normalized FFO of $232.9 million, or $1.50 per share. The company also issued 2025 guidance of $1.68 to $1.72 in normalized FFO per share and kept its quarterly dividend at $0.29 per share.

Key points

  • Q4 2024 net income attributable to CareTrust was $52.1 million ($0.29 per diluted share), versus $26.3 million ($0.22) in Q4 2023.
  • Q4 2024 normalized FFO was $72.9 million ($0.40 per share), versus $43.4 million ($0.36) a year earlier.
  • 2025 guidance: net income of $1.35 to $1.39 per diluted share, normalized FFO of $1.68 to $1.72, and normalized FAD of $1.72 to $1.76, based on 187.5 million shares.
  • As of February 12, 2025, the company had $750.0 million available under its ATM Program and no borrowings on its $1.2 billion revolving credit line.

The filing

CompanyCareTrust REIT (CTRE)
Form8-K, current report
Filed with the SECFeb 12, 2025, 4:07 PM ET
Accession number0001628280-25-005119

Items reported: 2.02 Results of Operations7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 12, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.